HomeAMRN • NASDAQ
add
Amarin Corporation PLC
Nakaraang pagsara
$9.36
Sakop ng araw
$8.84 - $9.34
Sakop ng taon
$7.08 - $20.60
Market cap
182.40M USD
Average na Volume
123.10K
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 62.31M | -16.61% |
Gastos sa pagpapatakbo | 42.96M | -13.63% |
Net na kita | -48.62M | -741.00% |
Net profit margin | -78.03 | -908.14% |
Kita sa bawat share | -0.40 | — |
EBITDA | -15.31M | -295.22% |
Aktuwal na % ng binabayarang buwis | 2.58% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 294.22M | -8.25% |
Kabuuang asset | 685.35M | -17.60% |
Kabuuang sagutin | 199.17M | -28.76% |
Kabuuang equity | 486.18M | — |
Natitirang share | 20.71M | — |
Presyo para makapag-book | 0.40 | — |
Return on assets | -5.59% | — |
Return on capital | -7.75% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -48.62M | -741.00% |
Cash mula sa mga operasyon | -13.31M | -1,963.57% |
Cash mula sa pag-invest | -22.84M | 67.83% |
Cash mula sa financing | 17.00K | -79.52% |
Net change in cash | -36.13M | 49.51% |
Malayang cash flow | 13.85M | 215.08% |
Tungkol
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa, a prescription grade omega-3 fatty acid.
In July 2012, their lead-candidate drug named Vascepa received FDA-approval, competing against GlaxoSmithKline's Lovaza. Wikipedia
Itinatag
Mar 1, 1989
Headquarters
Website
Mga Empleyado
275
